Ben Tre Pharmaceutical JSC
Ben Tre Pharmaceutical Joint Stock Company manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally. The company offers drugs in injectable, infusion, pill, and lotion forms. The company provides products covering various therapeutic areas, including central nervous system, respiratory system, endocrinology, obstetrics and gynecology, anti-allergic, cardiovascul… Read more
Ben Tre Pharmaceutical JSC (DBT) - Net Assets
Latest net assets as of : ₫- VND
Based on the latest financial reports, Ben Tre Pharmaceutical JSC (DBT) has net assets worth ₫- VND as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₫-) and total liabilities (₫-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₫- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Ben Tre Pharmaceutical JSC - Net Assets Trend (None–None)
This chart illustrates how Ben Tre Pharmaceutical JSC's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Ben Tre Pharmaceutical JSC (None–None)
The table below shows the annual net assets of Ben Tre Pharmaceutical JSC from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Ben Tre Pharmaceutical JSC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Ben Tre Pharmaceutical JSC Competitors by Market Cap
The table below lists competitors of Ben Tre Pharmaceutical JSC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Tarena International Inc
NASDAQ:TCTM
|
$4.92 Million |
|
Cauldron Energy Limited
PINK:CAULF
|
$4.92 Million |
|
LEGEND POWER SYS INC.
F:XLE1
|
$4.92 Million |
|
NIPPON PROLOGIS REIT INC.
F:9NPA
|
$4.93 Million |
|
Annexin Pharmaceuticals AB
ST:ANNX
|
$4.92 Million |
|
Moment Group AB
ST:MOMENT
|
$4.91 Million |
|
HPP Holdings Bhd
KLSE:0228
|
$4.91 Million |
|
Verb Technology Company Inc
NASDAQ:VERB
|
$4.91 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ben Tre Pharmaceutical JSC's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Ben Tre Pharmaceutical JSC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Ben Tre Pharmaceutical JSC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Ben Tre Pharmaceutical JSC's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $1,979,636,361,615
- Average return on equity (ROE) among peers: 16.56%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ben Tre Pharmaceutical JSC (DBT) | ₫- | N/A | N/A | $4.92 Million |
| Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) | $1.66 Trillion | 16.57% | 0.36x | $183.29 Million |
| DHG Pharmaceutical JSC (DHG) | $3.57 Trillion | 20.74% | 0.25x | $29.78 Million |
| DOMESCO Medical Import Export JSC (DMC) | $1.25 Trillion | 18.58% | 0.22x | $21.40K |
| Imexpharm Corp (IMP) | $1.73 Trillion | 12.12% | 0.21x | $119.65 Million |
| Traphaco JSC (TRA) | $1.69 Trillion | 14.81% | 0.39x | $27.57 Million |